GDF-15 and Early Outcomes After LVAD Implantation
Recruiting
Observational Study
Advanced Heart Failure
Left Ventricular Assist Device Implantation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 48 (estimated)
- Sponsor
- Akdeniz University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This observational study aims to investigate the association between preoperative GDF-15 levels and early postoperative outcomes in patients undergoing left ventricular assist device (LVAD) implantation. The study will evaluate whether elevated preoperative GDF-15 levels are associated with adverse early outcomes, including postoperative complications and mortality. The findings may help improve p…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:Adults aged 18 years and older
Patients with advanced heart failure undergoing LVAD implantation
Availability of preoperative GDF-15 measurement
Ability to provide written informed consent or consent provided by a legally authorized representative, according to local regulation…
Contacts